SOURCE: Solos Endoscopy, Inc.

August 03, 2006 08:30 ET

Solos Endoscopy, Inc. and Lifeline Biotechnologies, Inc. to Host Nationwide Teleconference to Update Shareholders on Dividend

BOSTON, MA -- (MARKET WIRE) -- August 3, 2006 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSE) and Lifeline Biotechnologies, Inc. (PINKSHEETS: LBTN) are pleased to announce that the Companies will be hosting a Nationwide Teleconference on August 8th at 4:15 p.m. (Eastern Daylight Time) to update the financial community on recent events that affect Solos Endoscopy, Inc., Lifeline Biotechnologies, Inc., and their shareholders.

Lifeline Biotechnologies, Inc. recently announced that shareholders of record as of August 18th, 2006 will receive 1 new share of Solos Endoscopy, Inc. for approximately every 100 shares of LBTN they own as of the record date. Lifeline Biotechnologies shareholders will maintain their stock ownership of LBTN and will receive a dividend in Solos Endoscopy, Inc., a leading medical instrumentation company with worldwide distribution to major hospitals, surgical centers, and physician's offices.

"We are excited to have the chance to update our shareholders and the financial community about the new direction of our company and our imminent stock dividend," stated Jim Holmes, President of Lifeline Biotechnologies, Inc.

"This is a great opportunity for us to speak to our future shareholders and describe our company and business model to the investing community," stated Robert Segersten, President of Solos Endoscopy, Inc.

There is expected to be a high demand for the call-in lines for this Nationwide Teleconference and space will be limited. Please call today 1-866-THE-APPL(E) to reserve your place and receive the information which will enable you to participate in the conference.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office Additional information is available on the Company's website at: www.solosendoscopy.com.

About Lifeline Biotechnologies, Inc.:

Lifeline Biotechnologies develops and acquires undervalued companies which have innovative technology in the Medical, Nutraceutical, and Energy Industries, to increase the growth of the Company. Lifeline Biotechnologies continues to seek out and capitalize on emerging technologies that will change the medical community. More information is available at the company's website: www.lbtn.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Information

  • CONTACT:
    Investor Relations
    1-866-THE-APPL(E)